ArriVent BioPharma (AVBP) Operating Expenses (2023 - 2026)
ArriVent BioPharma (AVBP) posted Operating Expenses of $46.1 million for Q1 2026, up 18.77% sequentially from $38.8 million in Q4 2025, and down 30.94% YoY from $66.8 million in Q1 2025.
ArriVent BioPharma (AVBP) Operating Expenses (2023 - 2026) Analysis & Trends
ArriVent BioPharma has reported Operating Expenses for 4 years, with the latest figure at $46.1 million in Q1 2026.
- Quarterly Operating Expenses fell 30.94% year-over-year to $46.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $156.9 million (up 11.73% YoY) and the FY2025 annual result came in at $177.5 million, up 88.25% from the prior year.
- Operating Expenses grew to $46.1 million in Q1 2026 per AVBP's latest filing, from $38.8 million in the prior quarter.
- Over five years, Operating Expenses peaked at $66.8 million in Q1 2025 and troughed at $12.2 million in Q1 2023.
- A 4-year average of $30.2 million and a median of $24.2 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses jumped 222.98% in 2025, then plunged 30.94% in 2026.
- Over 4 years, Operating Expenses stood at $23.1 million in 2023, then climbed by 2.54% to $23.7 million in 2024, then surged by 63.78% to $38.8 million in 2025, then increased by 18.77% to $46.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $46.1 million, $38.8 million, and $38.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | ArriVent BioPharma | 1.43 Bn | 1.43 Bn | - | 52.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 52.69 Mn |
| Mar 31, 2026 | 46.11 Mn |
| Dec 31, 2025 | 38.82 Mn |
| Sep 30, 2025 | 38.32 Mn |
| Jun 30, 2025 | 33.62 Mn |
| Mar 31, 2025 | 66.77 Mn |
| Dec 31, 2024 | 23.71 Mn |
| Sep 30, 2024 | 24.23 Mn |
| Jun 30, 2024 | 25.70 Mn |
| Mar 31, 2024 | 20.67 Mn |
| Dec 31, 2023 | 23.12 Mn |
| Sep 30, 2023 | 16.72 Mn |
| Jun 30, 2023 | 22.58 Mn |
| Mar 31, 2023 | 12.17 Mn |